Trovagene raises $7.1M in direct public offering

Cancer company Trovagene Inc. (NASDAQ:TROV) raised $7.1 million through the sale of 6.2 million shares at $1.15 in a registered direct offering on July 14. In a concurrent private placement, the inves...